Core Viewpoint - Clorox's dividend yield of 4.07% is significantly higher than its peers, reflecting investor skepticism about its near-term prospects rather than superior dividend growth potential [1] Dividend Performance - The dividend has increased from $450 million in fiscal 2018 to $602 million in fiscal 2025, a growth of 33.8%, with a compound annual growth rate of approximately 5.2% [2] - Recent quarterly payments have stabilized at $1.24, up from $1.22 in the first half of 2025 [2] - The payout ratio improved to 61.4% in fiscal 2025, with operating cash flow at $981 million covering the $602 million dividend [5][7] Operational Challenges - Clorox's gross margin has compressed to 43.2% due to consumers opting for cheaper alternatives, impacting sales volumes despite price increases [9] - The company reported a profit margin of 11.2% and an operating margin of 14.1%, trailing behind Procter & Gamble's margins [10] - A $580 million SAP enterprise resource planning implementation caused significant disruption, with second-quarter fiscal 2026 results showing revenue of $1.67 billion but adjusted earnings per share of $1.39, missing analyst expectations [8] Strategic Moves - Clorox's $2.25 billion acquisition of GOJO Industries aims to strengthen its health and hygiene portfolio but adds integration risk during a challenging operational period [11] - The company faces a $14.15 million fine from the Consumer Product Safety Commission for delayed warnings about bacterial contamination in Pine-Sol products [12] Investor Sentiment - Clorox repurchased $332 million worth of shares in fiscal 2025, indicating management's confidence in the valuation, though institutional investors show mixed conviction [13] - The current dividend appears safe in the near term based on cash flow coverage, but the margin for error has narrowed [14] Future Outlook - Management reaffirmed fiscal 2026 adjusted earnings guidance of $5.95 to $6.30 per share, projecting gross margin expansion in the latter half of the fiscal year [14] - The upcoming CAGNY Conference will be critical for investors to assess guidance for fiscal 2027 and the timeline for margin recovery [15] - The 48-year dividend growth streak provides historical comfort, but recent cash flow volatility highlights the pressures faced by the company [16]

Core Viewpoint - Clorox's 4.07% dividend yield is attractive but faces challenges due to operational turbulence and margin pressure, raising questions about sustainability in the face of potential risks ahead [1][2] Dividend Performance - Clorox paid $1.24 per share on February 13, 2026, marking 48 consecutive years of dividend increases, with a total dividend payout of $602 million for fiscal 2025 [1] - The company generated $981 million in operating cash flow, resulting in a 61.4% payout ratio, indicating adequate coverage of the dividend [1] - Free cash flow for fiscal 2025 was $761 million, providing 1.26x coverage after capital expenditures, a recovery from fiscal 2024's 0.81x coverage [1][2] - The dividend has grown 33.8% from $450 million in fiscal 2018 to $602 million in fiscal 2025, with a compound annual growth rate of approximately 5.2% [1] Yield Context - Clorox's 4.07% yield is significantly higher than Procter & Gamble's 2.63% and Kimberly-Clark's 4.76%, reflecting investor skepticism about Clorox's near-term prospects [1] - The stock has seen a year-to-date gain of 26.21% as of February 12, 2026, but is down 11.86% over the past year and 20.32% over five years, indicating a depressed stock price of $125.82 [1] Operational Challenges - Clorox's gross margin has compressed to 43.2% due to consumers opting for cheaper alternatives, with management projecting only flat to 1% organic growth for the latter half of fiscal 2026 [1] - The company's profit margin of 11.2% and operating margin of 14.1% are below those of Procter & Gamble, highlighting an efficiency disadvantage [1] Strategic Moves - Clorox's $2.25 billion acquisition of GOJO Industries aims to strengthen its health and hygiene portfolio but introduces integration risks during a challenging operational period [1] - The company faces a $14.15 million fine from the Consumer Product Safety Commission for delayed warnings about bacterial contamination in Pine-Sol products, involving 37 million bottles recalled [1] Future Outlook - Management has reaffirmed fiscal 2026 adjusted earnings guidance of $5.95 to $6.30 per share, projecting gross margin expansion in the latter half of the year [1] - The upcoming CAGNY Conference on February 19, 2026, will be critical for investors to assess guidance for fiscal 2027 and the timeline for margin recovery [2]

Market Overview - The stock market experienced a sell-off, with the Dow Jones Industrial Average, S&P 500, and Nasdaq all declining by more than 1% on Thursday [1] - Concerns about AI disruption are affecting various industries, including software, financials, office real estate, and logistics [1] Company Insights - Alphabet's stock increased after announcing a significant upgrade to its Gemini 3 Deep Think reasoning model, which can now tackle modern science and engineering challenges, indicating its leadership in AI development [1] - The company made a small purchase of Alphabet shares and is considering further investments during market weakness [1] Housing Market Data - Existing home sales in January fell by 8.4% month-over-month to a seasonally adjusted rate of 3.91 million, which is 4.4% lower than January 2025 [1] - The January report may dampen expectations for a housing market recovery, but the impact of unusually cold weather is noted as a complicating factor [1] - The downtick in the 30-year fixed mortgage rate to around 6.1% in January from 6.19% in December is not expected to significantly influence sales trends [1] Economic Indicators - Upcoming earnings reports are expected from several companies, including Coinbase, Arista Networks, and Moderna [1] - The January Consumer Price Index (CPI) report is anticipated to be released on Friday [1]

Core Viewpoint - Pentair has achieved its 50th consecutive annual dividend increase, with an 8.0% raise in 2026, indicating strong growth potential despite a modest yield compared to traditional dividend aristocrats [1][2] Dividend Performance - The current quarterly dividend is $0.27 per share, translating to an annualized payout of $1.08, resulting in a yield of approximately 1.01% [1] - The 8.0% increase in 2026 follows an 8.7% increase in 2025, showcasing a significant acceleration compared to typical mid-single-digit increases from competitors like Johnson & Johnson (4.8%) and Procter & Gamble (5.0%) [1][2] Cash Flow and Payout Ratio - Pentair's payout ratio stands at 20.2%, significantly lower than Johnson & Johnson's 50.5%, indicating a conservative approach to dividend payments [1] - Operating cash flow for fiscal 2025 was $814.8 million, with only $164.3 million paid out in dividends, allowing for a coverage ratio of 4.55 times [1] Earnings and Profitability - The company reported a net income of $653.8 million in fiscal 2025, a 4.5% increase from the previous year, on revenue of $4.18 billion [1] - Operating margin improved to 20.5%, and the operating cash flow to net income ratio was 1.25x, indicating strong cash conversion [1] Total Return and Growth Potential - Over the past five years, Pentair shares have returned 103.18%, outperforming Johnson & Johnson (68.0%) and Procter & Gamble (43.58%) [1] - The stock is currently down 1.73% year-to-date, presenting potential entry opportunities for investors [1] Historical Context of Dividend Growth - Pentair's dividend growth streak spans 50 years, with total growth of 237.5% from a quarterly payment of $0.08 in 1999 to $0.27 today [1] - The company has maintained its dividend through various economic challenges, including the 2008 financial crisis and the pandemic [1] Investment Outlook - Pentair is positioned as a 'Growth Aristocrat' with a strong dividend scorecard, reflecting its low payout ratio and robust financial coverage [1] - Analysts currently rate Pentair as a 'Buy' with a target price indicating an 11.4% upside [1]

Core Viewpoint - Colgate-Palmolive maintains a 63-year streak of dividend increases, with a current yield of 2.19%, which is lower than competitors like Kimberly-Clark and Procter & Gamble, raising questions about its premium valuation against modest revenue growth [1][2]. Dividend Scorecard - Colgate's quarterly dividend of $0.52 translates to an annualized $2.06 per share, yielding just over 2% at current prices around $97.16 [1]. - The yield is below competitors, with Kimberly-Clark at 4.76% and Procter & Gamble at 2.63% [1]. - Colgate trades at a P/E ratio of 36, significantly higher than Kimberly-Clark's 22, indicating a premium valuation based on brand reliability rather than income generation [1]. Growth vs. Income - Colgate increased its dividend by 4% in early 2025, aligning with peers like PepsiCo and Coca-Cola, which raised dividends by 5% and 5.15% respectively [1]. - The payout ratio is 80%, based on fiscal 2025 net income of $2.13 billion and an annualized dividend run rate of approximately $1.7 billion [1]. Earnings Quality and Coverage Capacity - Colgate generated $4.35 billion in operating income and $3.96 billion in EBITDA for fiscal 2025, indicating strong capacity to meet dividend obligations [1]. - The operating margin stands at 21%, showcasing pricing power in its product categories despite slowing revenue growth [1]. Total Return Context - Colgate shares have appreciated 23.71% year-to-date and 14.75% over the past year, contributing to a total return of nearly 17% annually when dividends are reinvested [1]. - In contrast, Kimberly-Clark's shares declined by 14.89% over the past year despite a higher yield [1]. Valuation Premium - Colgate's P/E ratio of 36 and PEG ratio of 3.6 reflect market optimism about future growth, although this premium leaves less room for error in case of operational setbacks [1]. - The price-to-sales ratio of 3.78 is higher than most consumer staples peers, indicating strong brand strength but also potential vulnerability [1]. Peer Comparison - Colgate is positioned in the middle among consumer staples, lacking the diversification of Procter & Gamble and the scale of PepsiCo [1]. - Its focus on oral care, personal care, and pet nutrition allows for resilient cash generation, even with moderated revenue growth [1]. Dividend Aristocrat Premium - The 63-year dividend increase streak signifies management discipline and a strong shareholder-first culture, surviving various economic challenges [1]. - However, aristocrat status does not guarantee future returns, as consistent dividends do not ensure price appreciation without earnings growth [1].

Market Overview - Wall Street experienced declines, particularly in technology stocks, with a notable rotation into cyclical sectors like industrials, which are performing strongly [1] - Key holdings in the portfolio, including Dupont, Dover, Honeywell, Linde, GE Vernova, and Eaton, have shown extraordinary year-to-date performance, while the S&P 500 has only slightly increased [1] Portfolio Management - The decision to trim positions in Eaton and Procter & Gamble was made to maintain portfolio discipline as these stocks benefited from the market rotation [1] - A prior decision to reduce Cisco holdings before its earnings report was validated as shares fell over 10% following the announcement [1] Cisco's Performance - Cisco reported a strong quarter with networking order growth exceeding 20%, marking six consecutive quarters of double-digit growth, driven by AI hardware demand [1] - Despite the positive growth, a dip in gross margins due to rising memory prices caused concern among investors [1] - Management's actions to leverage pricing power and robust order growth led to an increase in full-year earnings guidance, indicating a commitment to long-term performance [1] Impact on Related Companies - Apple shares fell over 3% in response to Cisco's warning about memory prices, with PC makers Dell Technologies and HP Inc. experiencing even larger declines of 9% and 6%, respectively [1] - Memory prices are a critical factor for these companies, raising concerns about future margins [1] Apple Developments - Apple is facing challenges with the rollout of the Siri upgrade, which is now expected to be staggered throughout the year instead of a full launch in March [1] - Despite the delay, strong iPhone sales are ongoing, suggesting that the slower Siri rollout may not significantly impact Apple's overall performance [1] - The partnership with Google's Gemini AI models has created optimism regarding the potential value of the Siri upgrade [1]

Core Viewpoint - The company is making strategic trades by selling shares of Eaton and Procter & Gamble to lock in profits as the stock market approaches overbought conditions, while maintaining a focus on potential growth in technology stocks [1] Eaton - The company is selling 20 shares of Eaton at approximately $403 each, reducing its weighting in the portfolio from 2.75% to 2.55% and decreasing the share count to 250 [1] - Eaton's shares have increased by 27% year to date, prompting the company to raise its price target to $425 due to strong momentum in data center orders [1] - The decision to trim the position is aimed at securing gains from the recent performance over the past month and a half [1] Procter & Gamble - The company is selling 50 shares of Procter & Gamble at around $162, decreasing its weighting in the portfolio from about 1.9% to 1.7% and reducing the share count to 425 [1] - Procter & Gamble shares have risen 13% year to date, and the company downgraded its rating to a hold equivalent after the stock reached a new high for 2026 [1] - The initial investment in Procter & Gamble was made in anticipation of a rebound in the consumer staples sector, which has proven successful as the sector gains popularity [1] Market Conditions - The S&P Short Range Oscillator indicates that the stock market is nearing overbought conditions, leading to the decision to book profits in the aforementioned stocks [1] - Despite the overall market conditions, technology stocks, particularly the Magnificent Seven, are perceived to have room for growth, prompting the company to maintain a focus on selectively increasing positions in these areas, especially in Alphabet [1]

Core Insights - Procter & Gamble's Native brand has launched a feature-length microsoap titled "The Golden Pear Affair," co-produced with dentsu Entertainment and Pixie USA, marking a new chapter in brand storytelling [1][2] - The microsoap consists of 55 short-form episodes totaling just under 80 minutes, designed for mobile-first viewing, blending fast-paced storytelling with themes of romance and adventure [1][2] - The series integrates Native's limited edition fragrance collection, Global Flavors, into its narrative, enhancing the viewer's experience with scents inspired by global locations [1][2] Company Overview - Native, founded in 2015, focuses on clean personal care products made from naturally derived ingredients, including deodorants and body washes [1][2] - P&G Studios develops compelling narratives that connect P&G brands with audiences, having produced various notable projects across different platforms [1][2] - Dentsu Entertainment specializes in creating content that fosters cultural connections, with a commitment to innovation in entertainment and brand partnerships [2][3] Product and Marketing Strategy - The Golden Pear Affair is marketed as a new model for brand-led entertainment, combining storytelling, social-native formats, and commerce into an immersive experience [1][2] - The full series is available for $9.99, with individual episodes for purchase, and includes promotional elements that encourage audience engagement through brand interactions [1][2] - The cast will promote the series on their social media platforms, driving traffic to the viewing site and enhancing audience engagement [1][2]

RT Sama Hoole (@SamaHoole)In 1961, the American Heart Association had 1.7 million members and recommended butter, eggs, and whole milk.In 1962, after receiving a $1.7 million donation from Procter & Gamble (makers of Crisco), they suddenly changed their position to recommend seed oils over animal fats.The science didn't change. The funding did.Your health guidelines have always been for sale to the highest bidder. ...

Core Insights - Elixiir Foods has raised $9 million in seed funding to launch a ready-to-eat food platform targeting urban Indian consumers with "affordable premium" products [1][2] - The startup aims to build a tech and supply chain infrastructure to support its operations, starting with the Delhi NCR region [2][4] - The platform will offer a variety of products including fresh produce, dairy, meat, poultry, seafood, and daily essentials, with a focus on gourmet ingredients [3] Company Overview - Elixiir Foods was founded in 2026 by industry veterans Arvind Mediratta and Ambuj Narayan, who have extensive experience in the FMCG and retail sectors [4][5] - Mediratta has 34 years of experience in the industry, having held senior roles at major companies like Walmart and Procter & Gamble, while Narayan has over 25 years of experience in retail strategy [5] Market Context - The Indian urban consumer market is becoming increasingly health and brand conscious due to rising GDP, per capita income, and urbanization [6] - The foodtech sector is witnessing growth with various D2C brands and startups addressing the demand for healthier alternatives and product diversification [6][7] - Competitors in the ready-to-eat category include established names like Licious, Country Delight, and iD Fresh Food, indicating a competitive landscape [7]